Regression of pressure overload-induced left ventricular hypertrophy in mice

被引:79
作者
Gao, XM
Kiriazis, H
Moore, XL
Feng, XH
Sheppard, K
Dart, A
Du, XJ
机构
[1] Baker Heart Res Inst, Expt Cardiol Lab, Melbourne, Vic 8008, Australia
[2] Alfred Hosp, Alfred Heart Ctr, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
来源
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY | 2005年 / 288卷 / 06期
关键词
aortic banding; cardiac function/remodeling; model;
D O I
10.1152/ajpheart.00836.2004
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
As a prelude to investigating the mechanism of regression of pressure overload-induced left ventricular (LV) hypertrophy (LVH), we studied the time course for the development and subsequent regression of LVH as well as accompanying alterations in cardiac function, histology, and gene expression. Mice were subjected to aortic banding for 4 or 8 wk to establish LVH, and regression was initiated by release of aortic banding for 6 wk. Progressive increase in LV mass and gradual chamber dilatation and dysfunction occurred after aortic banding. LVH was also associated with myocyte enlargement, interstitial fibrosis, and enhanced expression of atrial natriuretic peptide, collagen I, collagen III, and matrix metalloproteinase-2 but suppressed expression of alpha-myosin heavy chain and sarcoplasmic reticulum Ca2+-ATPase. Aortic debanding completely or partially reversed LVH, chamber dilatation and dysfunction, myocyte size, interstitial fibrosis, and gene expression pattern, each with a distinct time course. The extent of LVH regression was dependent on the duration of pressure overload, evidenced by the fact that restoration of LV structure and function was complete in animals subjected to 4 wk of aortic banding but incomplete in animals subjected to 8 wk of aortic banding. In conclusion, LVH regression comprises a variety of morphological, functional, and genetic components that show distinct time courses. A longer period of pressure overload is associated with a slower rate of LVH regression.
引用
收藏
页码:H2702 / H2707
页数:6
相关论文
共 38 条
[1]
Böcker W, 2000, J CARDIOVASC PHARM, V36, P481
[2]
Electrophysiological effects accompanying regression of left ventricular hypertrophy [J].
Botchway, AN ;
Turner, MA ;
Sheridan, DJ ;
Flores, NA ;
Fry, CH .
CARDIOVASCULAR RESEARCH, 2003, 60 (03) :510-517
[3]
REACTIVE AND REPARATIVE MYOCARDIAL FIBROSIS IN ARTERIAL-HYPERTENSION IN THE RAT [J].
BRILLA, CG ;
WEBER, KT .
CARDIOVASCULAR RESEARCH, 1992, 26 (07) :671-677
[4]
IMPAIRED DIASTOLIC FUNCTION AND CORONARY RESERVE IN GENETIC-HYPERTENSION - ROLE OF INTERSTITIAL FIBROSIS AND MEDIAL THICKENING OF INTRAMYOCARDIAL CORONARY-ARTERIES [J].
BRILLA, CG ;
JANICKI, JS ;
WEBER, KT .
CIRCULATION RESEARCH, 1991, 69 (01) :107-115
[5]
Regression of myocardial fibrosis in hypertensive heart disease: diverse effects of various antihypertensive drugs [J].
Brilla, CG .
CARDIOVASCULAR RESEARCH, 2000, 46 (02) :324-331
[6]
β2-adrenergic receptor overexpression exacerbates development of heart failure after aortic stenosis [J].
Du, XJ ;
Autelitano, DJ ;
Dilley, RJ ;
Wang, BH ;
Dart, AM ;
Woodcock, EA .
CIRCULATION, 2000, 101 (01) :71-77
[7]
Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy [J].
Friddle, CJ ;
Koga, T ;
Rubin, EM ;
Bristow, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (12) :6745-6750
[8]
Sex hormones and cardiomyopathic phenotype induced by cardiac β2-adrenergic receptor overexpression [J].
Gao, XM ;
Agrotis, A ;
Autelitano, DJ ;
Percy, E ;
Woodcock, EA ;
Jennings, GL ;
Dart, AM ;
Du, XJ .
ENDOCRINOLOGY, 2003, 144 (09) :4097-4105
[9]
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death [J].
Haider, AW ;
Larson, MG ;
Benjamin, EJ ;
Levy, D .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 32 (05) :1454-1459
[10]
Phenotype-driven genetic approaches in mice - High-throughput phenotyping for discovering new models of cardiovascular disease [J].
Hoit, BD ;
Nadeau, JH .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (02) :82-89